However, GDC-0449 at the dose of 50 mg/kg, a concentration that can achieve 100% TGI in medulloblastoma sensitive to Smo inhibitors 14, showed obvious resistance to the growth of SmoA1 tumors (Figure 6B-D). This evidence concerns the gene SMO and medulloblastoma.